A hot flash on tamoxifen metabolism

J Natl Cancer Inst. 2003 Dec 3;95(23):1734-5. doi: 10.1093/jnci/djg129.
No abstract available

Publication types

  • Editorial
  • Review
  • Comment

MeSH terms

  • Antidepressive Agents, Second-Generation / pharmacokinetics*
  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / pharmacokinetics*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology
  • Cyclohexanols / pharmacokinetics
  • Cytochrome P-450 CYP2D6 / metabolism*
  • Estrogen Receptor Modulators / adverse effects
  • Estrogen Receptor Modulators / pharmacokinetics*
  • Estrogen Replacement Therapy / adverse effects
  • Female
  • Fluoxetine / pharmacokinetics
  • Hot Flashes / chemically induced
  • Humans
  • Hydroxylation
  • Paroxetine / pharmacology
  • Randomized Controlled Trials as Topic
  • Selective Estrogen Receptor Modulators / adverse effects
  • Selective Estrogen Receptor Modulators / pharmacokinetics*
  • Tamoxifen / adverse effects
  • Tamoxifen / analogs & derivatives*
  • Tamoxifen / metabolism*
  • Tamoxifen / pharmacokinetics*
  • Venlafaxine Hydrochloride

Substances

  • Antidepressive Agents, Second-Generation
  • Antineoplastic Agents, Hormonal
  • Cyclohexanols
  • Estrogen Receptor Modulators
  • Selective Estrogen Receptor Modulators
  • Fluoxetine
  • Tamoxifen
  • afimoxifene
  • Paroxetine
  • Venlafaxine Hydrochloride
  • Cytochrome P-450 CYP2D6
  • N-desmethyltamoxifen